{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["local field potential recordings", "mice", "molecular modeling", "pentylenetetrazole", "schisandrin B", "seizures", "toxicity", "zebrafish"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37629132", "DateCompleted": {"Year": "2023", "Month": "08", "Day": "28"}, "DateRevised": {"Year": "2023", "Month": "08", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "08", "Day": "18"}], "Language": ["eng"], "ELocationID": ["12949", "10.3390/ijms241612949"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "24", "Issue": "16", "PubDate": {"Year": "2023", "Month": "Aug", "Day": "18"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "In Silico Analysis, Anticonvulsant Activity, and Toxicity Evaluation of Schisandrin B in Zebrafish Larvae and Mice.", "Abstract": {"AbstractText": ["The aim of this study is to evaluate the anticonvulsant potential of schisandrin B, a main ingredient of <i>Schisandra chinensis</i> extracts. Schisandrin B showed anticonvulsant activity in the zebrafish larva pentylenetetrazole acute seizure assay but did not alter seizure thresholds in the intravenous pentylenetetrazole test in mice. Schisandrin B crosses the blood-brain barrier, which we confirmed in our in silico and in vivo analyses; however, the low level of its unbound fraction in the mouse brain tissue may explain the observed lack of anticonvulsant activity. Molecular docking revealed that the anticonvulsant activity of the compound in larval zebrafish might have been due to its binding to a benzodiazepine site within the GABA<sub>A</sub> receptor and/or the inhibition of the glutamate NMDA receptor. Although schisandrin B showed a beneficial anticonvulsant effect, toxicological studies revealed that it caused serious developmental impairment in zebrafish larvae, underscoring its teratogenic properties. Further detailed studies are needed to precisely identify the properties, pharmacological effects, and safety of schisandrin B."]}, "AuthorList": [{"Identifier": ["0000-0002-9446-7343"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Animal Physiology and Pharmacology, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Sk\u0142odowska University, Akademicka 19, 20-033 Lublin, Poland."}], "LastName": "Nieoczym", "ForeName": "Dorota", "Initials": "D"}, {"Identifier": ["0000-0002-3061-1633"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemical Neuroscience Group, Centre for Molecular Medicine Norway, University of Oslo, Gaustadalleen 21, Forskningsparken, 0349 Oslo, Norway."}], "LastName": "Banono", "ForeName": "Nancy Saana", "Initials": "NS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physical Chemistry, Institute of Chemical Sciences, Faculty of Chemistry, Maria Curie-Sk\u0142odowska University, Pl. M. Curie-Sk\u0142odowskiej 3/243, 20-031 Lublin, Poland."}], "LastName": "St\u0119pnik", "ForeName": "Katarzyna", "Initials": "K"}, {"Identifier": ["0000-0001-8679-9623"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modeling Laboratory, Faculty of Pharmacy, Medical University of Lublin, 4A Chodzki St., 20-093 Lublin, Poland."}], "LastName": "Kaczor", "ForeName": "Agnieszka A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental and Clinical Pharmacology, Medical University of Lublin, Jaczewskiego St. 8b, 20-090 Lublin, Poland."}, {"Identifier": [], "Affiliation": "Clinical Provincial Hospital No. 2 St. Jadwiga Krolowej in Rzeszow, Lwowska St. 60, 35-301 Rzeszow, Poland."}], "LastName": "Szybkowski", "ForeName": "Przemys\u0142aw", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemical Neuroscience Group, Centre for Molecular Medicine Norway, University of Oslo, Gaustadalleen 21, Forskningsparken, 0349 Oslo, Norway."}], "LastName": "Esguerra", "ForeName": "Camila Vicencio", "Initials": "CV"}, {"Identifier": ["0000-0001-7076-600X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy with Medicinal Plants Garden, Medical University of Lublin, Chod\u017aki St. 1, 20-093 Lublin, Poland."}], "LastName": "Kukula-Koch", "ForeName": "Wirginia", "Initials": "W"}, {"Identifier": ["0000-0001-8857-847X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental and Clinical Pharmacology, Medical University of Lublin, Jaczewskiego St. 8b, 20-090 Lublin, Poland."}], "LastName": "Gawel", "ForeName": "Kinga", "Initials": "K"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anticonvulsants"}, {"RegistryNumber": "02XA4X3KZW", "NameOfSubstance": "schizandrin B"}, {"RegistryNumber": "WM5Z385K7T", "NameOfSubstance": "Pentylenetetrazole"}, {"RegistryNumber": "3KX376GY7L", "NameOfSubstance": "Glutamic Acid"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, GABA-A"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["toxicity"], "DescriptorName": "Anticonvulsants"}, {"QualifierName": [], "DescriptorName": "Zebrafish"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["toxicity"], "DescriptorName": "Pentylenetetrazole"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Seizures"}, {"QualifierName": [], "DescriptorName": "Glutamic Acid"}, {"QualifierName": [], "DescriptorName": "Larva"}, {"QualifierName": [], "DescriptorName": "Receptors, GABA-A"}], "CoiStatement": "P.S. is a volunteer at the Department of Experimental and Clinical Pharmacology, Medical University of Lublin, Poland. The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Weltha L., Reemmer J., Boison D. The role of adenosine in epilepsy. Brain Res. Bull. 2019;151:46\u201354. doi: 10.1016/j.brainresbull.2018.11.008.", "ArticleIdList": ["10.1016/j.brainresbull.2018.11.008", "PMC6527499", "30468847"]}, {"Citation": "Beyenburg S., Mitchell A.J., Schmidt D., Elger C.E., Reuber M. Anxiety in patients with epilepsy: Systematic review and suggestions for clinical management. Epilepsy Behav. 2005;7:161\u2013171. doi: 10.1016/j.yebeh.2005.05.014.", "ArticleIdList": ["10.1016/j.yebeh.2005.05.014", "16054870"]}, {"Citation": "Hingray C., McGonigal A., Kotwas I., Micoulaud-Franchi J.A. The Relationship Between Epilepsy and Anxiety Disorders. Curr. Psychiatry Rep. 2019;21:40. doi: 10.1007/s11920-019-1029-9.", "ArticleIdList": ["10.1007/s11920-019-1029-9", "31037466"]}, {"Citation": "Rao G., Mashkouri S., Aum D., Marcet P., Borlongan C.V. Contemplating stem cell therapy for epilepsy-induced neuropsychiatric symptoms. Neuropsychiatr. Dis. Treat. 2017;13:585\u2013596. doi: 10.2147/NDT.S114786.", "ArticleIdList": ["10.2147/NDT.S114786", "PMC5328607", "28260906"]}, {"Citation": "Kanner A.M., Helmstaedter C., Sadat-Hossieny Z., Meador K. Cognitive disorders in epilepsy I: Clinical experience, real-world evidence and recommendations. Seizure. 2020;83:216\u2013222. doi: 10.1016/j.seizure.2020.10.009.", "ArticleIdList": ["10.1016/j.seizure.2020.10.009", "33127274"]}, {"Citation": "Fattorusso A., Matricardi S., Mencaroni E., Dell\u2019Isola G.B., Di Cara G., Striano P., Verrotti A. The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies. Front. Neurol. 2021;12:674483. doi: 10.3389/fneur.2021.674483.", "ArticleIdList": ["10.3389/fneur.2021.674483", "PMC8258148", "34239494"]}, {"Citation": "Wahab A. Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development. Pharmaceuticals. 2010;3:2090\u20132110. doi: 10.3390/ph3072090.", "ArticleIdList": ["10.3390/ph3072090", "PMC4036655", "27713344"]}, {"Citation": "Perucca P., Gilliam F.G. Adverse effects of antiepileptic drugs. Lancet Neurol. 2012;11:792\u2013802. doi: 10.1016/S1474-4422(12)70153-9.", "ArticleIdList": ["10.1016/S1474-4422(12)70153-9", "22832500"]}, {"Citation": "Lin C.H., Hsieh C.L. Chinese Herbal Medicine for Treating Epilepsy. Front. Neurosci. 2021;15:682821. doi: 10.3389/fnins.2021.682821.", "ArticleIdList": ["10.3389/fnins.2021.682821", "PMC8284486", "34276290"]}, {"Citation": "Aghdash S.N. Herbal Medicine in the Treatment of Epilepsy. Curr. Drug Targets. 2021;22:356\u2013367. doi: 10.2174/1389450121999201001152221.", "ArticleIdList": ["10.2174/1389450121999201001152221", "33023444"]}, {"Citation": "Zhang M., Xu L., Yang H. Schisandra chinensis Fructus and Its Active Ingredients as Promising Resources for the Treatment of Neurological Diseases. Int. J. Mol. Sci. 2018;19:1970. doi: 10.3390/ijms19071970.", "ArticleIdList": ["10.3390/ijms19071970", "PMC6073455", "29986408"]}, {"Citation": "Wang M., Li N., Jing S., Wang C., Sun J., Li H., Liu J., Chen J. Schisandrin B exerts hypnotic effects in PCPA-treated rats by increasing hypothalamic 5-HT and \u03b3-aminobutyric acid levels. Exp. Ther. Med. 2020;20:142. doi: 10.3892/etm.2020.9271.", "ArticleIdList": ["10.3892/etm.2020.9271", "PMC7571383", "33093880"]}, {"Citation": "Zhang C., Mao X., Zhao X., Liu Z., Liu B., Li H., Bi K., Jia Y. Gomisin N isolated from Schisandra chinensis augments pentobarbital-induced sleep behaviors through the modification of the serotonergic and GABAergic system. Fitoterapia. 2014;96:123\u2013130. doi: 10.1016/j.fitote.2014.04.017.", "ArticleIdList": ["10.1016/j.fitote.2014.04.017", "24785966"]}, {"Citation": "Fan X., Elkin K., Shi Y., Zhang Z., Cheng Y., Gu J., Liang J., Wang C., Ji X. Schisandrin B improves cerebral ischemia and reduces reperfusion injury in rats through TLR4/NF-\u03baB signaling pathway inhibition. Neurol. Res. 2020;42:693\u2013702. doi: 10.1080/01616412.2020.1782079.", "ArticleIdList": ["10.1080/01616412.2020.1782079", "32657248"]}, {"Citation": "Jeong E.J., Lee H.K., Lee K.Y., Jeon B.J., Kim D.H., Park J.H., Song J.H., Huh J., Lee J.H., Sung S.H. The effects of lignan-riched extract of Shisandra chinensis on amyloid-\u03b2-induced cognitive impairment and neurotoxicity in the cortex and hippocampus of mouse. J. Ethnopharmacol. 2013;146:347\u2013354. doi: 10.1016/j.jep.2013.01.003.", "ArticleIdList": ["10.1016/j.jep.2013.01.003", "23333311"]}, {"Citation": "Xu M., Yan T., Fan K., Wang M., Qi Y., Xiao F., Bi K., Jia Y. Polysaccharide of Schisandra Chinensis Fructus ameliorates cognitive decline in a mouse model of Alzheimer\u2019s disease. J. Ethnopharmacol. 2019;237:354\u2013365. doi: 10.1016/j.jep.2019.02.046.", "ArticleIdList": ["10.1016/j.jep.2019.02.046", "30844489"]}, {"Citation": "Li Z., Liu X.C., Li R., Chang J. Reduction of A\u03b2 Generation by Schisandrin B through Restraining Beta-Secretase 1 Transcription and Translation. Med. Sci. Monit. 2018;24:1219\u20131224. doi: 10.12659/MSM.905127.", "ArticleIdList": ["10.12659/MSM.905127", "PMC5841190", "29487280"]}, {"Citation": "Giridharan V.V., Thandavarayan R.A., Sato S., Ko K.M., Konishi T. Prevention of scopolamine-induced memory deficits by schisandrin B, an antioxidant lignan from Schisandra chinensis in mice. Free Radic. Res. 2011;45:950\u2013958. doi: 10.3109/10715762.2011.571682.", "ArticleIdList": ["10.3109/10715762.2011.571682", "21615274"]}, {"Citation": "Jiang Z.J., Wang C.Y., Xie X., Yang J.F., Huang J.N., Cao Z.P., Xiao P., Li C.H. Schizandrin ameliorates ovariectomy-induced memory impairment, potentiates neurotransmission and exhibits antioxidant properties. Br. J. Pharmacol. 2015;172:2479\u20132492. doi: 10.1111/bph.13078.", "ArticleIdList": ["10.1111/bph.13078", "PMC4409901", "25573619"]}, {"Citation": "Song Y., Shan B., Zeng S., Zhang J., Jin C., Liao Z., Wang T., Zeng Q., He H., Wei F., et al. Raw and wine processed Schisandra chinensis attenuate anxiety like behavior via modulating gut microbiota and lipid metabolism pathway. J. Ethnopharmacol. 2021;266:113426. doi: 10.1016/j.jep.2020.113426.", "ArticleIdList": ["10.1016/j.jep.2020.113426", "33007392"]}, {"Citation": "Yeh C.-H., Lin M.-W., Lin H.-C. Anti-neuroinflammaiton and antidepressant effects of Schisandrin B in mice. FASEB J. 2013;27:1099.5. doi: 10.1096/fasebj.27.1_supplement.1099.5.", "ArticleIdList": ["10.1096/fasebj.27.1_supplement.1099.5"]}, {"Citation": "Wu Y., Li Z.C., Yao L.Q., Li M., Tang M. Schisandrin B alleviates acute oxidative stress via modulation of the Nrf2/Keap1-mediated antioxidant pathway. Appl. Physiol. Nutr. Metab. 2019;44:1\u20136. doi: 10.1139/apnm-2018-0251.", "ArticleIdList": ["10.1139/apnm-2018-0251", "29742356"]}, {"Citation": "Norton W. Zebrafish Protocols for Neurobehavioral Research. Springer; Berlin/Heidelberg, Germany: 2012. Measuring Larval Zebrafish Behavior: Locomotion, Thigmotaxis, and Startle; pp. 3\u201320.", "ArticleIdList": ["10.1007/978-1-61779-597-8_1"]}, {"Citation": "Basnet R.M., Zizioli D., Taweedet S., Finazzi D., Memo M. Zebrafish Larvae as a Behavioral Model in Neuropharmacology. Biomedicines. 2019;7:23. doi: 10.3390/biomedicines7010023.", "ArticleIdList": ["10.3390/biomedicines7010023", "PMC6465999", "30917585"]}, {"Citation": "Gawel K., Kukula-Koch W., Banono N.S., Nieoczym D., Targowska-Duda K.M., Czernicka L., Parada-Turska J., Esguerra C.V. 6-Gingerol, a Major Constituent of Zingiber officinale Rhizoma, Exerts Anticonvulsant Activity in the Pentylenetetrazole-Induced Seizure Model in Larval Zebrafish. Int. J. Mol. Sci. 2021;22:7745. doi: 10.3390/ijms22147745.", "ArticleIdList": ["10.3390/ijms22147745", "PMC8305044", "34299361"]}, {"Citation": "Gawel K., Turski W.A., van der Ent W., Mathai B.J., Kirstein-Smardzewska K.J., Simonsen A., Esguerra C.V. Phenotypic Characterization of Larval Zebrafish (Danio rerio) with Partial Knockdown of the cacna1a Gene. Mol. Neurobiol. 2020;57:1904\u20131916. doi: 10.1007/s12035-019-01860-x.", "ArticleIdList": ["10.1007/s12035-019-01860-x", "PMC7118054", "31875924"]}, {"Citation": "Abraham M.H., Tak\u00e1cs-Nov\u00e1k K., Mitchell R.C. On the partition of ampholytes: Application to blood-brain distribution. J. Pharm. Sci. 1997;86:310\u2013315. doi: 10.1021/js960328j.", "ArticleIdList": ["10.1021/js960328j", "9050798"]}, {"Citation": "Abraham M.H. The factors that influence permeation across the blood-brain barrier. Eur. J. Med. Chem. 2004;39:235\u2013240. doi: 10.1016/j.ejmech.2003.12.004.", "ArticleIdList": ["10.1016/j.ejmech.2003.12.004", "15051171"]}, {"Citation": "St\u0119pnik K., Kukula-Koch W. In Silico Studies on Triterpenoid Saponins Permeation through the Blood-Brain Barrier Combined with Postmortem Research on the Brain Tissues of Mice Affected by Astragaloside IV Administration. Int. J. Mol. Sci. 2020;21:2534. doi: 10.3390/ijms21072534.", "ArticleIdList": ["10.3390/ijms21072534", "PMC7177733", "32260588"]}, {"Citation": "Hu T., Zhang J., Wang J., Sha L., Xia Y., Ortyl T.C., Tian X., Chen L. Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies. J. Med. Chem. 2023;66:4434\u20134467. doi: 10.1021/acs.jmedchem.2c01975.", "ArticleIdList": ["10.1021/acs.jmedchem.2c01975", "37012671"]}, {"Citation": "Bhat J.U., Nizami Q., Asiaf A., Parray S.A., Ahmad S.T., Aslam M., Khanam R., Mujeeb M., Umar S., Siddiqi A. Anticonvulsant activity of methanolic and aqueous extracts of Melissa parviflora in experimentally induced Swiss albino mice. EXCLI J. 2012;11:1\u20136.", "ArticleIdList": ["PMC4897659", "27298604"]}, {"Citation": "Gawel K., Kukula-Koch W., Nieoczym D., Stepnik K., Ent W.V., Banono N.S., Tarabasz D., Turski W.A., Esguerra C.V. The Influence of Palmatine Isolated from Berberis sibiricaRadix on Pentylenetetrazole-Induced Seizures in Zebrafish. Cells. 2020;9:1233. doi: 10.3390/cells9051233.", "ArticleIdList": ["10.3390/cells9051233", "PMC7290958", "32429356"]}, {"Citation": "Ya\u2019u J., Yaro A.H., Malami S., Musa M.A., Abubakar A., Yahaya S.M., Chindo B.A., Anuka J.A., Hussaini I.M. Anticonvulsant activity of aqueous fraction of Carissa edulis root bark. Pharm. Biol. 2015;53:1329\u20131338. doi: 10.3109/13880209.2014.981280.", "ArticleIdList": ["10.3109/13880209.2014.981280", "25856720"]}, {"Citation": "Nasser M.I., Zhu S., Chen C., Zhao M., Huang H., Zhu P. A Comprehensive Review on Schisandrin B and Its Biological Properties. Oxid. Med. Cell. Longev. 2020;2020:2172740. doi: 10.1155/2020/2172740.", "ArticleIdList": ["10.1155/2020/2172740", "PMC7102409", "32256947"]}, {"Citation": "Zhu N., Cai C., Zhou A., Zhao X., Xiang Y., Zeng C. Schisandrin B Prevents Hind Limb from Ischemia-Reperfusion-Induced Oxidative Stress and Inflammation via MAPK/NF-\u03baB Pathways in Rats. Biomed Res. Int. 2017;2017:4237973. doi: 10.1155/2017/4237973.", "ArticleIdList": ["10.1155/2017/4237973", "PMC5494555", "28706944"]}, {"Citation": "Chen N., Ko M. Schisandrin B-induced glutathione antioxidant response and cardioprotection are mediated by reactive oxidant species production in rat hearts. Biol. Pharm. Bull. 2010;33:825\u2013829. doi: 10.1248/bpb.33.825.", "ArticleIdList": ["10.1248/bpb.33.825", "20460761"]}, {"Citation": "Chen Q., Bao L., Lv L., Xie F., Zhou X., Zhang H., Zhang G. Schisandrin B regulates macrophage polarization and alleviates liver fibrosis via activation of PPAR\u03b3. Ann. Transl. Med. 2021;9:1500. doi: 10.21037/atm-21-4602.", "ArticleIdList": ["10.21037/atm-21-4602", "PMC8573433", "34805362"]}, {"Citation": "Ba Q., Cui C., Wen L., Feng S., Zhou J., Yang K. Schisandrin B shows neuroprotective effect in 6-OHDA-induced Parkinson\u2019s disease via inhibiting the negative modulation of miR-34a on Nrf2 pathway. Biomed. Pharmacother. 2015;75:165\u2013172. doi: 10.1016/j.biopha.2015.07.034.", "ArticleIdList": ["10.1016/j.biopha.2015.07.034", "26282218"]}, {"Citation": "Hu X.-L., Guo C., Hou J.-Q., Feng J.-H., Zhang X.-Q., Xiong F., Ye W.-C., Wang H. Stereoisomers of Schisandrin B Are Potent ATP Competitive GSK-3\u03b2 Inhibitors with Neuroprotective Effects against Alzheimer\u2019s Disease: Stereochemistry and Biological Activity. ACS Chem. Neurosci. 2019;10:996\u20131007. doi: 10.1021/acschemneuro.8b00252.", "ArticleIdList": ["10.1021/acschemneuro.8b00252", "29944335"]}, {"Citation": "Wei B., Li Q., Fan R., Su D., Chen X., Jia Y., Bi K. Determination of monoamine and amino acid neurotransmitters and their metabolites in rat brain samples by UFLC-MS/MS for the study of the sedative-hypnotic effects observed during treatment with S. chinensis. J. Pharm. Biomed. Anal. 2014;88:416\u2013422. doi: 10.1016/j.jpba.2013.09.022.", "ArticleIdList": ["10.1016/j.jpba.2013.09.022", "24176746"]}, {"Citation": "Li N., Liu J., Wang M., Yu Z., Zhu K., Gao J., Wang C., Sun J., Chen J., Li H. Sedative and hypnotic effects of Schisandrin B through increasing GABA/Glu ratio and upregulating the expression of GABAA in mice and rats. Biomed. Pharmacother. 2018;103:509\u2013516. doi: 10.1016/j.biopha.2018.04.017.", "ArticleIdList": ["10.1016/j.biopha.2018.04.017", "29677536"]}, {"Citation": "Gawel K., Langlois M., Martins T., van der Ent W., Tiraboschi E., Jacmin M., Crawford A.D., Esguerra C.V. Seizing the moment: Zebrafish epilepsy models. Neurosci. Biobehav. Rev. 2020;116:1\u201320. doi: 10.1016/j.neubiorev.2020.06.010.", "ArticleIdList": ["10.1016/j.neubiorev.2020.06.010", "32544542"]}, {"Citation": "Gawel K., Banono N.S., Michalak A., Esguerra C.V. A critical review of zebrafish schizophrenia models: Time for validation? Neurosci. Biobehav. Rev. 2019;107:6\u201322. doi: 10.1016/j.neubiorev.2019.08.001.", "ArticleIdList": ["10.1016/j.neubiorev.2019.08.001", "31381931"]}, {"Citation": "Malhi S.M., Jawed H., Hanif F., Ashraf N., Zubair F., Siddiqui B.S., Begum S., Kabir N., Simjee S.U. Modulation of c-Fos and BDNF protein expression in pentylenetetrazole-kindled mice following the treatment with novel antiepileptic compound HHL-6. Biomed Res. Int. 2014;2014:876712. doi: 10.1155/2014/876712.", "ArticleIdList": ["10.1155/2014/876712", "PMC3925558", "24605339"]}, {"Citation": "Yang H., Shan W., Zhu F., Yu T., Fan J., Guo A., Li F., Yang X., Wang Q. C-Fos mapping and EEG characteristics of multiple mice brain regions in pentylenetetrazol-induced seizure mice model. Neurol. Res. 2019;41:749\u2013761. doi: 10.1080/01616412.2019.1610839.", "ArticleIdList": ["10.1080/01616412.2019.1610839", "31038018"]}, {"Citation": "Baraban S.C., Taylor M.R., Castro P.A., Baier H. Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience. 2005;131:759\u2013768. doi: 10.1016/j.neuroscience.2004.11.031.", "ArticleIdList": ["10.1016/j.neuroscience.2004.11.031", "15730879"]}, {"Citation": "Skupien-Jaroszek A., Walczak A., Czaban I., Pels K.K., Szczepankiewicz A.A., Krawczyk K., Ruszczycki B., Wilczynski G.M., Dzwonek J., Magalska A. The interplay of seizures-induced axonal sprouting and transcription-dependent Bdnf repositioning in the model of temporal lobe epilepsy. PLoS ONE. 2021;16:e0239111. doi: 10.1371/journal.pone.0239111.", "ArticleIdList": ["10.1371/journal.pone.0239111", "PMC8177504", "34086671"]}, {"Citation": "Binder D.K., Croll S.D., Gall C.M., Scharfman H.E. BDNF and epilepsy: Too much of a good thing? Trends Neurosci. 2001;24:47\u201353. doi: 10.1016/S0166-2236(00)01682-9.", "ArticleIdList": ["10.1016/S0166-2236(00)01682-9", "11163887"]}, {"Citation": "Kim J., Lee S., Kang S., Kim S.H., Kim J.C., Yang M., Moon C. Brain-derived neurotropic factor and GABAergic transmission in neurodegeneration and neuroregeneration. Neural Regen. Res. 2017;12:1733\u20131741. doi: 10.4103/1673-5374.217353.", "ArticleIdList": ["10.4103/1673-5374.217353", "PMC5696856", "29171440"]}, {"Citation": "Hansch C. Quantitative approach to biochemical structure-activity relationships. Acc. Chem. Res. 1969;2:232\u2013239. doi: 10.1021/ar50020a002.", "ArticleIdList": ["10.1021/ar50020a002"]}, {"Citation": "Liu X., Smith B.J., Chen C., Callegari E., Becker S.L., Chen X., Cianfrogna J., Doran A.C., Doran S.D., Gibbs J.P., et al. Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: An experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding. J. Pharmacol. Exp. Ther. 2005;313:1254\u20131262. doi: 10.1124/jpet.104.079319.", "ArticleIdList": ["10.1124/jpet.104.079319", "15743928"]}, {"Citation": "Hammarlund-Udenaes M., Frid\u00e9n M., Syv\u00e4nen S., Gupta A. On the rate and extent of drug delivery to the brain. Pharm. Res. 2008;25:1737\u20131750. doi: 10.1007/s11095-007-9502-2.", "ArticleIdList": ["10.1007/s11095-007-9502-2", "PMC2469271", "18058202"]}, {"Citation": "Platts J.A., Abraham M.H., Zhao Y.H., Hersey A., Ijaz L., Butina D. Correlation and prediction of a large blood-brain distribution data set\u2014An LFER study. Eur. J. Med. Chem. 2001;36:719\u2013730. doi: 10.1016/S0223-5234(01)01269-7.", "ArticleIdList": ["10.1016/S0223-5234(01)01269-7", "11672881"]}, {"Citation": "Hansch C., Fujita T. p-\u03c3-\u03c0 Analysis. A Method for the Correlation of Biological Activity and Chemical Structure. J. Am. Chem. Soc. 1964;86:1616\u20131626. doi: 10.1021/ja01062a035.", "ArticleIdList": ["10.1021/ja01062a035"]}, {"Citation": "Hitchcock S.A., Pennington L.D. Structure-brain exposure relationships. J. Med. Chem. 2006;49:7559\u20137583. doi: 10.1021/jm060642i.", "ArticleIdList": ["10.1021/jm060642i", "17181137"]}, {"Citation": "Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997;23:3\u201325. doi: 10.1016/S0169-409X(96)00423-1.", "ArticleIdList": ["10.1016/S0169-409X(96)00423-1", "11259830"]}, {"Citation": "Gozalbes R., Pineda-Lucena A. QSAR-based solubility model for drug-like compounds. Bioorganic Med. Chem. 2010;18:7078\u20137084. doi: 10.1016/j.bmc.2010.08.003.", "ArticleIdList": ["10.1016/j.bmc.2010.08.003", "20810286"]}, {"Citation": "Young R.C., Mitchell R.C., Brown T.H., Ganellin C.R., Griffiths R., Jones M., Rana K.K., Saunders D., Smith I.R., Sore N.E., et al. Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. J. Med. Chem. 1988;31:656\u2013671. doi: 10.1021/jm00398a028.", "ArticleIdList": ["10.1021/jm00398a028", "2894467"]}, {"Citation": "Rose K., Hall L.H., Kier L.B. Modeling Blood-Brain Barrier Partitioning Using the Electrotopological State. J. Chem. Inf. Comput. Sci. 2002;42:651\u2013666. doi: 10.1021/ci010127n.", "ArticleIdList": ["10.1021/ci010127n", "12086527"]}, {"Citation": "Lombardo F., Blake J.F., Curatolo W.J. Computation of brain-blood partitioning of organic solutes via free energy calculations. J. Med. Chem. 1996;39:4750\u20134755. doi: 10.1021/jm960163r.", "ArticleIdList": ["10.1021/jm960163r", "8941388"]}, {"Citation": "Kaliszan R., Markuszewski M. Brain/blood distribution described by a combination of partition coefficient and molecular mass. Int. J. Pharm. 1996;145:9\u201316. doi: 10.1016/S0378-5173(96)04712-6.", "ArticleIdList": ["10.1016/S0378-5173(96)04712-6"]}, {"Citation": "Ong S., Liu H., Qiu X., Bhat G., Pidgeon C. Membrane Partition Coefficients Chromatographically Measured Using Immobilized Artificial Membrane Surfaces. Anal. Chem. 1995;67:755\u2013762. doi: 10.1021/ac00100a011.", "ArticleIdList": ["10.1021/ac00100a011", "7702190"]}, {"Citation": "Russo G., Grumetto L., Szucs R., Barbato F., Lynen F. Screening therapeutics according to their uptake across the blood-brain barrier: A high throughput method based on immobilized artificial membrane liquid chromatography-diode-array-detection coupled to electrospray-time-of-flight mass spectrometry. Eur. J. Pharm. Biopharm. 2018;127:72\u201384. doi: 10.1016/j.ejpb.2018.02.004.", "ArticleIdList": ["10.1016/j.ejpb.2018.02.004", "29427629"]}, {"Citation": "Darrouzain F., Dallet P., Dubost J.-P., Ismaili L., Pehourcq F., Bannwarth B., Matoga M., Guillaume Y.C. Molecular lipophilicity determination of a huperzine series by HPLC: Comparison of C18 and IAM stationary phases. J. Pharm. Biomed. Anal. 2006;41:228\u2013232. doi: 10.1016/j.jpba.2005.11.011.", "ArticleIdList": ["10.1016/j.jpba.2005.11.011", "16406443"]}, {"Citation": "Ong S., Liu H., Pidgeon C. Immobilized-artificial-membrane chromatography: Measurements of membrane partition coefficient and predicting drug membrane permeability. J. Chromatogr. A. 1996;728:113\u2013128. doi: 10.1016/0021-9673(95)00837-3.", "ArticleIdList": ["10.1016/0021-9673(95)00837-3", "8673230"]}, {"Citation": "Kotecha J., Shah S., Rathod I., Subbaiah G. Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs. Int. J. Pharm. 2007;333:127\u2013135. doi: 10.1016/j.ijpharm.2006.10.010.", "ArticleIdList": ["10.1016/j.ijpharm.2006.10.010", "17095172"]}, {"Citation": "Jandera P., Fischer J., Effenberger H. Characterisation of retention in micellar high-performance liquid chromatography and in micellar electrokinetic chromatography using lipophilicity and polarity indices. J. Chromatogr. A. 1998;807:57\u201370. doi: 10.1016/S0021-9673(98)00067-3.", "ArticleIdList": ["10.1016/S0021-9673(98)00067-3", "11358218"]}, {"Citation": "Kim S.S., Im S.H., Yang J.Y., Lee Y.R., Kim G.R., Chae J.S., Shin D.S., Song J.S., Ahn S., Lee B.H., et al. Zebrafish as a Screening Model for Testing the Permeability of Blood-Brain Barrier to Small Molecules. Zebrafish. 2017;14:322\u2013330. doi: 10.1089/zeb.2016.1392.", "ArticleIdList": ["10.1089/zeb.2016.1392", "28488933"]}, {"Citation": "Fleming A., Diekmann H., Goldsmith P. Functional characterisation of the maturation of the blood-brain barrier in larval zebrafish. PLoS ONE. 2013;8:e77548. doi: 10.1371/journal.pone.0077548.", "ArticleIdList": ["10.1371/journal.pone.0077548", "PMC3797749", "24147021"]}, {"Citation": "Zhu H., Zhang X., Guan J., Cui B., Zhao L., Zhao X. Pharmacokinetics and tissue distribution study of schisandrin B in rats by ultra-fast liquid chromatography with tandem mass spectrometry. J. Pharm. Biomed. Anal. 2013;78\u201379:136\u2013140. doi: 10.1016/j.jpba.2013.01.041.", "ArticleIdList": ["10.1016/j.jpba.2013.01.041", "23474814"]}, {"Citation": "Wang Z., You L., Cheng Y., Hu K., Wang Z., Cheng Y., Yang J., Yang Y., Wang G. Investigation of pharmacokinetics, tissue distribution and excretion of schisandrin B in rats by HPLC\u2013MS/MS. Biomed. Chromatogr. 2018;32:e4069. doi: 10.1002/bmc.4069.", "ArticleIdList": ["10.1002/bmc.4069", "28833320"]}, {"Citation": "Mandhane S.N., Aavula K., Rajamannar T. Timed pentylenetetrazol infusion test: A comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice. Seizure. 2007;16:636\u2013644. doi: 10.1016/j.seizure.2007.05.005.", "ArticleIdList": ["10.1016/j.seizure.2007.05.005", "17570689"]}, {"Citation": "Spreafico M., Jacobson M.P. In silico prediction of brain exposure: Drug free fraction, unbound brain to plasma concentration ratio and equilibrium half-life. Curr. Top. Med. Chem. 2013;13:813\u2013820. doi: 10.2174/1568026611313070004.", "ArticleIdList": ["10.2174/1568026611313070004", "PMC4005893", "23578025"]}, {"Citation": "Mateus A., Matsson P., Artursson P. A high-throughput cell-based method to predict the unbound drug fraction in the brain. J. Med. Chem. 2014;57:3005\u20133010. doi: 10.1021/jm401963n.", "ArticleIdList": ["10.1021/jm401963n", "PMC3985417", "24601604"]}, {"Citation": "Afrikanova T., Serruys A.S., Buenafe O.E., Clinckers R., Smolders I., de Witte P.A., Crawford A.D., Esguerra C.V. Validation of the zebrafish pentylenetetrazol seizure model: Locomotor versus electrographic responses to antiepileptic drugs. PLoS ONE. 2013;8:e54166. doi: 10.1371/journal.pone.0054166.", "ArticleIdList": ["10.1371/journal.pone.0054166", "PMC3544809", "23342097"]}, {"Citation": "Brodovskaya A., Kapur J. Anticonvulsant dopamine type 2 receptor agonist activates inhibitory parvalbumin interneurons. Epilepsia. 2021;62:e147\u2013e152. doi: 10.1111/epi.17004.", "ArticleIdList": ["10.1111/epi.17004", "PMC9299960", "34331457"]}, {"Citation": "Turski L., Cavalheiro E.A., Bortolotto Z.A., Ikonomidou-Turski C., Kleinrok Z., Turski W.A. Dopamine-sensitive anticonvulsant site in the rat striatum. J. Neurosci. 1988;8:4027\u20134037. doi: 10.1523/JNEUROSCI.08-11-04027.1988.", "ArticleIdList": ["10.1523/JNEUROSCI.08-11-04027.1988", "PMC6569478", "3183711"]}, {"Citation": "Wahnschaffe U., L\u00f6scher W. Anticonvulsant effects of ipsilateral but not contralateral microinjections of the dopamine D2 agonist LY 171555 into the nucleus accumbens of amygdala-kindled rats. Brain Res. 1991;553:181\u2013187. doi: 10.1016/0006-8993(91)90822-D.", "ArticleIdList": ["10.1016/0006-8993(91)90822-D", "1681980"]}, {"Citation": "Turski W.A., Cavalheiro E.A., Ikonomidou C., Bortolotto Z.A., Klockgether T., Turski L. Dopamine control of seizure propagation: Intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures. Synapse. 1990;5:113\u2013119. doi: 10.1002/syn.890050205.", "ArticleIdList": ["10.1002/syn.890050205", "2137942"]}, {"Citation": "Venzi M., David F., Bellet J., Cavaccini A., Bombardi C., Crunelli V., Di Giovanni G. Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures. Neuropharmacology. 2016;108:292\u2013304. doi: 10.1016/j.neuropharm.2016.04.016.", "ArticleIdList": ["10.1016/j.neuropharm.2016.04.016", "PMC4920646", "27085605"]}, {"Citation": "Kaczor A.A., Rutkowska E., Bartuzi D., Targowska-Duda K.M., Matosiuk D., Selent J. Computational methods for studying G protein-coupled receptors (GPCRs) Methods Cell Biol. 2016;132:359\u2013399. doi: 10.1016/bs.mcb.2015.11.002.", "ArticleIdList": ["10.1016/bs.mcb.2015.11.002", "26928552"]}, {"Citation": "Bartuzi D., Kaczor A.A., Targowska-Duda K.M., Matosiuk D. Recent Advances and Applications of Molecular Docking to G Protein-Coupled Receptors. Molecules. 2017;22:340. doi: 10.3390/molecules22020340.", "ArticleIdList": ["10.3390/molecules22020340", "PMC6155844", "28241450"]}, {"Citation": "Staro\u0144 J., Bugno R., Pietru\u015b W., Sata\u0142a G., Mordalski S., Warszycki D., Hogendorf A., Hogendorf A.S., Kalinowska-T\u0142u\u015bcik J., Lenda T., et al. Rationally designed N-phenylsulfonylindoles as a tool for the analysis of the non-basic 5-HT(6)R ligands binding mode. Eur. J. Med. Chem. 2021;209:112916. doi: 10.1016/j.ejmech.2020.112916.", "ArticleIdList": ["10.1016/j.ejmech.2020.112916", "33328102"]}, {"Citation": "Cunningham C.W., Rothman R.B., Prisinzano T.E. Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A. Pharmacol. Rev. 2011;63:316\u2013347. doi: 10.1124/pr.110.003244.", "ArticleIdList": ["10.1124/pr.110.003244", "PMC3082450", "21444610"]}, {"Citation": "Xiao F., Chen Z., Wei Z., Tian L. Hydrophobic Interaction: A Promising Driving Force for the Biomedical Applications of Nucleic Acids. Adv. Sci. 2020;7:2001048. doi: 10.1002/advs.202001048.", "ArticleIdList": ["10.1002/advs.202001048", "PMC7435255", "32832360"]}, {"Citation": "L\u00f6scher W., Rundfeldt C., H\u00f6nack D. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy. Eur. J. Neurosci. 1993;5:1545\u20131550. doi: 10.1111/j.1460-9568.1993.tb00224.x.", "ArticleIdList": ["10.1111/j.1460-9568.1993.tb00224.x", "7904524"]}, {"Citation": "Nasiri-Boroujeni S., Rahimi-Madiseh M., Lorigooini Z., Piroti K., Rafieian-Koupaei M., Amini-Khoei H. NMDA Receptor Mediates the Anticonvulsant Effect of Hydroalcoholic Extract of Artemisia persica in PTZ-Induced Seizure in Mice. Evid.-Based Complement. Alternat Med. 2021;2021:6422451. doi: 10.1155/2021/6422451.", "ArticleIdList": ["10.1155/2021/6422451", "PMC8360731", "34394390"]}, {"Citation": "Hayes B.A., Balster R.L. Anticonvulsant properties of phencyclidine-like drugs in mice. Eur. J. Pharmacol. 1985;117:121\u2013125. doi: 10.1016/0014-2999(85)90480-7.", "ArticleIdList": ["10.1016/0014-2999(85)90480-7", "4085541"]}, {"Citation": "Treiman D.M. GABAergic mechanisms in epilepsy. Epilepsia. 2001;42((Suppl. 3)):8\u201312. doi: 10.1046/j.1528-1157.2001.042suppl.3008.x.", "ArticleIdList": ["10.1046/j.1528-1157.2001.042suppl.3008.x", "11520315"]}, {"Citation": "Nakonieczna S., Grabarska A., Gawel K., Wr\u00f3blewska-\u0141uczka P., Czerwonka A., Stepulak A., Kukula-Koch W. Isoquinoline Alkaloids from Coptis chinensis Franch: Focus on Coptisine as a Potential Therapeutic Candidate against Gastric Cancer Cells. Int. J. Mol. Sci. 2022;23:330. doi: 10.3390/ijms231810330.", "ArticleIdList": ["10.3390/ijms231810330", "PMC9499618", "36142236"]}, {"Citation": "Haigis A.C., Ottermanns R., Schiwy A., Hollert H., Legradi J. Getting more out of the zebrafish light dark transition test. Chemosphere. 2022;295:133863. doi: 10.1016/j.chemosphere.2022.133863.", "ArticleIdList": ["10.1016/j.chemosphere.2022.133863", "35124091"]}, {"Citation": "Rock S., Rodenburg F., Schaaf M.J.M., Tudorache C. Detailed Analysis of Zebrafish Larval Behaviour in the Light Dark Challenge Assay Shows That Diel Hatching Time Determines Individual Variation. Front. Physiol. 2022;13:827282. doi: 10.3389/fphys.2022.827282.", "ArticleIdList": ["10.3389/fphys.2022.827282", "PMC9036179", "35480044"]}, {"Citation": "Schn\u00f6rr S.J., Steenbergen P.J., Richardson M.K., Champagne D.L. Measuring thigmotaxis in larval zebrafish. Behav. Brain Res. 2012;228:367\u2013374. doi: 10.1016/j.bbr.2011.12.016.", "ArticleIdList": ["10.1016/j.bbr.2011.12.016", "22197677"]}, {"Citation": "St\u0119pnik K., Kukula-Koch W., Plazinski W., Gawel K., Gawe\u0142-B\u0119ben K., Khurelbat D., Boguszewska-Czubara A. Significance of Astragaloside IV from the Roots of Astragalus mongholicus as an Acetylcholinesterase Inhibitor-From the Computational and Biomimetic Analyses to the In Vitro and In Vivo Studies of Safety. Int. J. Mol. Sci. 2023;24:9152. doi: 10.3390/ijms24119152.", "ArticleIdList": ["10.3390/ijms24119152", "PMC10252989", "37298103"]}, {"Citation": "Di Paola D., Iaria C., Capparucci F., Arangia A., Crupi R., Cuzzocrea S., Span\u00f2 N., Gugliandolo E., Peritore A.F. Impact of Mycotoxin Contaminations on Aquatic Organisms: Toxic Effect of Aflatoxin B1 and Fumonisin B1 Mixture. Toxins. 2022;14:518. doi: 10.3390/toxins14080518.", "ArticleIdList": ["10.3390/toxins14080518", "PMC9414388", "36006180"]}, {"Citation": "Nieoczym D., Soca\u0142a K., Gawel K., Esguerra C.V., Wyska E., Wla\u017a P. Anticonvulsant Activity of Pterostilbene in Zebrafish and Mouse Acute Seizure Tests. Neurochem. Res. 2019;44:1043\u20131055. doi: 10.1007/s11064-019-02735-2.", "ArticleIdList": ["10.1007/s11064-019-02735-2", "PMC6482291", "30689162"]}, {"Citation": "Banono N.S., Gawel K., De Witte L., Esguerra C.V. Zebrafish Larvae Carrying a Splice Variant Mutation in cacna1d: A New Model for Schizophrenia-Like Behaviours? Mol. Neurobiol. 2021;58:877\u2013894. doi: 10.1007/s12035-020-02160-5.", "ArticleIdList": ["10.1007/s12035-020-02160-5", "PMC7843589", "33057948"]}, {"Citation": "Schr\u00f6dinger Release 2019-4: LigPrep. Schr\u00f6dinger, LLC; New York, NY, USA: 2019."}, {"Citation": "Sparaco R., K\u0119dzierska E., Kaczor A.A., Bielenica A., Magli E., Severino B., Corvino A., Gibu\u0142a-Tar\u0142owska E., Kotli\u0144ska J.H., Andreozzi G., et al. Synthesis, Docking Studies and Pharmacological Evaluation of Serotoninergic Ligands Containing a 5-Norbornene-2-Carboxamide Nucleus. Molecules. 2022;27:6492. doi: 10.3390/molecules27196492.", "ArticleIdList": ["10.3390/molecules27196492", "PMC9572521", "36235029"]}, {"Citation": "Kondej M., Wr\u00f3bel T.M., Targowska-Duda K.M., Leandro Mart\u00ednez A., Kosz\u0142a O., St\u0119pnicki P., Zi\u0119ba A., Paz A., Wronikowska-Denysiuk O., Loza M.I., et al. Multitarget Derivatives of D2AAK1 as Potential Antipsychotics: The Effect of Substitution in the Indole Moiety. ChemMedChem. 2022;17:e202200238. doi: 10.1002/cmdc.202200238.", "ArticleIdList": ["10.1002/cmdc.202200238", "35610178"]}, {"Citation": "Schr\u00f6dinger Release 2019-4: Epik. Schr\u00f6dinger, LLC; New York, NY, USA: 2019."}, {"Citation": "Poroikov V.V., Filimonov D.A., Borodina Y.V., Lagunin A.A., Kos A. Robustness of Biological Activity Spectra Predicting by Computer Program PASS for Noncongeneric Sets of Chemical Compounds. J. Chem. Inf. Comput. Sci. 2000;40:1349\u20131355. doi: 10.1021/ci000383k.", "ArticleIdList": ["10.1021/ci000383k", "11128093"]}, {"Citation": "Yin J., Chen K.-Y.M., Clark M.J., Hijazi M., Kumari P., Bai X.-C., Sunahara R.K., Barth P., Rosenbaum D.M. Structure of a D2 dopamine receptor\u2013G-protein complex in a lipid membrane. Nature. 2020;584:125\u2013129. doi: 10.1038/s41586-020-2379-5.", "ArticleIdList": ["10.1038/s41586-020-2379-5", "PMC7415663", "32528175"]}, {"Citation": "Kim K., Che T., Panova O., DiBerto J.F., Lyu J., Krumm B.E., Wacker D., Robertson M.J., Seven A.B., Nichols D.E., et al. Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor. Cell. 2020;182:1574\u20131588.e1519. doi: 10.1016/j.cell.2020.08.024.", "ArticleIdList": ["10.1016/j.cell.2020.08.024", "PMC7593816", "32946782"]}, {"Citation": "Wang H., Lv S., Stroebel D., Zhang J., Pan Y., Huang X., Zhang X., Paoletti P., Zhu S. Gating mechanism and a modulatory niche of human GluN1-GluN2A NMDA receptors. Neuron. 2021;109:2443\u20132456.e5. doi: 10.1016/j.neuron.2021.05.031.", "ArticleIdList": ["10.1016/j.neuron.2021.05.031", "34186027"]}, {"Citation": "Masiulis S., Desai R., Ucha\u0144ski T., Serna Martin I., Laverty D., Karia D., Malinauskas T., Zivanov J., Pardon E., Kotecha A., et al. GABAA receptor signalling mechanisms revealed by structural pharmacology. Nature. 2019;565:454\u2013459. doi: 10.1038/s41586-018-0832-5.", "ArticleIdList": ["10.1038/s41586-018-0832-5", "PMC6370056", "30602790"]}, {"Citation": "Schr\u00f6dinger Release 2019-4: BioLuminate. Schr\u00f6dinger, LLC; New York, NY, USA: 2019."}, {"Citation": "Ozvoldik K., Stockner T., Rammner B., Krieger E. Assembly of Biomolecular Gigastructures and Visualization with the Vulkan Graphics API. J. Chem. Inf. Model. 2021;61:5293\u20135303. doi: 10.1021/acs.jcim.1c00743.", "ArticleIdList": ["10.1021/acs.jcim.1c00743", "PMC8549067", "34528431"]}, {"Citation": "Schr\u00f6dinger Release 2019-4: Prime. Schr\u00f6dinger, LLC; New York, NY, USA: 2019."}, {"Citation": "Friesner R.A., Murphy R.B., Repasky M.P., Frye L.L., Greenwood J.R., Halgren T.A., Sanschagrin P.C., Mainz D.T. Extra Precision Glide:\u2009 Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein\u2212Ligand Complexes. J. Med. Chem. 2006;49:6177\u20136196. doi: 10.1021/jm051256o.", "ArticleIdList": ["10.1021/jm051256o", "17034125"]}, {"Citation": "Chou T.H., Epstein M., Michalski K., Fine E., Biggin P.C., Furukawa H. Structural insights into binding of therapeutic channel blockers in NMDA receptors. Nat. Struct. Mol. Biol. 2022;29:507\u2013518. doi: 10.1038/s41594-022-00772-0.", "ArticleIdList": ["10.1038/s41594-022-00772-0", "PMC10075384", "35637422"]}, {"Citation": "Magli E., K\u0119dzierska E., Kaczor A.A., Severino B., Corvino A., Perissutti E., Frecentese F., Saccone I., Massarelli P., Gibu\u0142a-Tar\u0142owska E., et al. Synthesis, docking studies, and pharmacological evaluation of 5HT2C ligands containing the N\u2032-cyanoisonicotinamidine or N\u2032-cyanopicolinamidine nucleus. Arch. Pharm. 2019;352:e1800373. doi: 10.1002/ardp.201800373.", "ArticleIdList": ["10.1002/ardp.201800373", "31025433"]}, {"Citation": "Magli E., K\u0119dzierska E., Kaczor A.A., Bielenica A., Severino B., Gibu\u0142a-Tar\u0142owska E., Kotli\u0144ska J.H., Corvino A., Sparaco R., Esposito G., et al. Synthesis, docking studies, and pharmacological evaluation of 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands. Arch. Pharm. 2021;354:e2000414. doi: 10.1002/ardp.202000414.", "ArticleIdList": ["10.1002/ardp.202000414", "33543794"]}, {"Citation": "Schr\u00f6dinger, LLC . The PyMOL Molecular Graphics System, version 2.0. Schr\u00f6dinger, LLC; New York, NY, USA: 2019."}, {"Citation": "Genheden S., Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert. Opin. Drug Discov. 2015;10:449\u2013461. doi: 10.1517/17460441.2015.1032936.", "ArticleIdList": ["10.1517/17460441.2015.1032936", "PMC4487606", "25835573"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "7", "Day": "23"}, {"Year": "2023", "Month": "8", "Day": "16"}, {"Year": "2023", "Month": "8", "Day": "16"}, {"Year": "2023", "Month": "8", "Day": "28", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "8", "Day": "26", "Hour": "10", "Minute": "42"}, {"Year": "2023", "Month": "8", "Day": "26", "Hour": "1", "Minute": "17"}, {"Year": "2023", "Month": "8", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["37629132", "PMC10455331", "10.3390/ijms241612949", "ijms241612949"]}}], "PubmedBookArticle": []}